tradingkey.logo
tradingkey.logo
Search

24H | Nuvalent Stock Soars 17% as GSK in Talks to Buy Cancer Biotech Nuvalent for More Than $9Bn

TigerJun 9, 2026 1:17 AM
facebooktwitterlinkedin
View all comments0

Nuvalent stock jumped17.45% in overnight trading.

GSK in talks to buy cancer biotech Nuvalent for more than $9 billion, FT reported.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

KeyAI